Literature DB >> 8396130

Roles for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes.

M Hirata1, Y Watanabe, M Yoshida, T Koga, S Ozaki.   

Abstract

Positional isomers of D-myo-inositol 1,4,5-trisphosphate (Ins(1,4,5)P3), Ins(1,4,6)P3, and Ins(1,3,6)P3 were examined to explore the roles for hydroxyl groups of Ins(1,4,5)P3, recognized by metabolic enzymes and by the receptor. Ins(1,4,6)P3 and Ins(1,3,6)P3 inhibited the dephosphorylation of [3H] Ins(1,4,5)P3 by the 5-phosphatase present in erythrocyte ghosts. The Ki value for the former compound was slightly lower than that for Ins(1,4,5)P3, while that for the latter compound was higher. In an assay of [3H] Ins(1,4,5)P3 3-kinase catalyzed by rat brain cytosol, Ins(1,4,6)P3 was as potent as Ins(1,4,5)P3 in inhibiting the phosphorylation, whereas Ins(1,3,6)P3 at concentrations up to 30 microM, was without effect. Ins(1,4,6)P3 and Ins(1,3,6)P3 at higher concentrations were effective in inhibiting [3H]Ins(1,4,5)P3 binding to purified Ins(1,4,5)P3 receptor. It would thus appear that the 2- and 3-hydroxyl groups of Ins(1,4,5)P3 are not primarily involved in recognition by metabolic enzymes, while 6-hydroxyl is slightly or severely involved in recognition by the phosphatase or kinase, respectively. On the other hand, although both 3-OH and 6-OH of Ins(1,4,5)P3 are important in binding by the Ins(1,4,5)P3 receptor to evoke the release of Ca2+, the 6-OH seems to be the more important.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396130

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Selective recognition of inositol phosphates by subtypes of the inositol trisphosphate receptor.

Authors:  E P Nerou; A M Riley; B V Potter; C W Taylor
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

2.  Inositol 1,4,5-trisphosphate receptor subtypes differentially recognize regioisomers of D-myo-inositol 1,4,5-trisphosphate.

Authors:  M Hirata; H Takeuchi; A M Riley; S J Mills; Y Watanabe; B V Potter
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

3.  Activation of PLC by an endogenous cytokine (GBP) in Drosophila S3 cells and its application as a model for studying inositol phosphate signalling through ITPK1.

Authors:  Yixing Zhou; Shilan Wu; Huanchen Wang; Yoichi Hayakawa; Gary S Bird; Stephen B Shears
Journal:  Biochem J       Date:  2012-12-01       Impact factor: 3.857

4.  Inositol trisphosphate analogues selective for types I and II inositol trisphosphate receptors exert differential effects on vasopressin-stimulated Ca2+ inflow and Ca2+ release from intracellular stores in rat hepatocytes.

Authors:  Roland B Gregory; Rachael Hughes; Andrew M Riley; Barry V L Potter; Robert A Wilcox; Greg J Barritt
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

5.  Preparation and characterization of a D-myo-inositol 1,4,5-trisphosphate-specific antibody.

Authors:  W R Shieh; C S Chen
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

Review 6.  Pharmacological modulation of intracellular Ca(2+) channels at the single-channel level.

Authors:  P Koulen; E C Thrower
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.682

7.  Both d- and l-Glucose Polyphosphates Mimic d-myo-Inositol 1,4,5-Trisphosphate: New Synthetic Agonists and Partial Agonists at the Ins(1,4,5)P3 Receptor.

Authors:  Megan L Shipton; Andrew M Riley; Ana M Rossi; Charles A Brearley; Colin W Taylor; Barry V L Potter
Journal:  J Med Chem       Date:  2020-05-06       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.